Join to View Full Profile
900 Centennial BlvdBldg 1Voorhees, NJ 08043
Phone+1 856-632-2667
Fax+1 856-735-6478
Dr. Jaslow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1999 - 2002
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1996 - 1999- Icahn School of Medicine at Mount SinaiClass of 1996
Certifications & Licensure
PA State Medical License 2002 - 2026
NJ State Medical License 2017 - 2025
DE State Medical License 2017 - 2023
NY State Medical License 1997 - 2002
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Clinical Trials
- Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer Start of enrollment: 2011 Dec 01
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax Start of enrollment: 2013 May 21
- Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer Start of enrollment: 2013 Apr 25
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsGenomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.Maysa Abu-Khalaf, Chun Wang, Zhenchao Zhang, Rui Luo, Weelic Chong
Cancers. 2022-06-10 - 30 citationsPrognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa M. Abu-Khalaf
Breast Cancer Research and Treatment. 2020-05-04 - 1 citationsEvaluation of a Technology-Based Survivor Care Plan for Breast Cancer Survivors: Pre-Post Pilot Study.Talya S. Laufer, Bryan Lerner, Anett Petrich, Anna Quinn, Leah Ernst
JMIR Cancer. 2019-12-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
